Bionano Genomics Sees Q2 Sales $7.500M-$7.800M vs $7.520M Est

Benzinga Newsdesk www.benzinga.com Positive 76.0%

Neg 0% Neu 0% Pos 76%

Bionano Genomics (NASDAQ:BNGO) sees Q2 sales of $7.500 million-$7.800 million vs $7.520 million analyst estimate.

Comments

No comments yet. Be the first!